SAFE Notes vs Convertible Notes: What UK Founders Need to Know About US Fundraising

The Rise of Convertible Instruments in Early-Stage Fundraising

For UK founders looking to raise capital from US investors, understanding the nuances of early-stage financing instruments is crucial. In recent years, convertible instruments, such as SAFE notes and convertible notes, have become increasingly popular alternatives to traditional equity financing. These instruments allow startups to raise capital quickly and efficiently, without the need for a formal valuation. This can be particularly advantageous for early-stage companies that may not yet have a proven track record or a clear path to profitability. Instead of issuing shares at a fixed price, convertible instruments allow investors to provide funding in exchange for the right to receive equity at a later date, typically upon the closing of a future priced financing round. This deferral of valuation is a key feature that makes these instruments so attractive to both founders and investors. It allows the company to focus on growth and development, while giving investors the opportunity to get in on the ground floor of a promising venture. However, while both SAFE notes and convertible notes serve a similar purpose, there are important differences between them that UK founders should be aware of before deciding which instrument is right for their company. For a broader perspective on the initial steps of US expansion, our article onThe Complete Legal Roadmap for UK Businesses Expanding into the U.S. provides a comprehensive overview.

Understanding SAFE Notes: A Founder-Friendly Approach

SAFE notes, which stands for Simple Agreement for Future Equity, were first introduced by the US accelerator Y Combinator in 2013. As the name suggests, SAFEs are designed to be a simpler and more founder-friendly alternative to convertible notes. Unlike convertible notes, which are debt instruments, SAFEs are not loans. They do not accrue interest and do not have a maturity date. This means that there is no pressure on the company to repay the investment if a future financing round does not occur. Instead, the SAFE simply remains outstanding until a conversion event takes place. SAFEs typically convert into equity at the next priced financing round, with the investor receiving shares at a discount to the price paid by the new investors. This discount is a key incentive for early-stage investors, as it rewards them for taking on the additional risk of investing in an unproven company. SAFEs can also include a valuation cap, which sets a maximum valuation at which the investment will convert. This provides downside protection for investors, as it ensures that they will receive a certain percentage of the company’s equity, even if the valuation at the next financing round is very high. The simplicity and founder-friendly nature of SAFEs have made them a popular choice for pre-seed and seed-stage companies in the US.

Convertible Notes: The Traditional Choice for Early-Stage Debt

Convertible notes, also known as convertible loan notes, have been a staple of early-stage fundraising for many years. Unlike SAFEs, convertible notes are debt instruments. This means that they have a maturity date, at which point the company must either repay the principal and accrued interest or convert the debt into equity. The interest rate on a convertible note is typically lower than that of a traditional loan, as the primary return for the investor is the equity they will receive upon conversion. Like SAFEs, convertible notes also typically include a discount and a valuation cap. The discount gives the investor the right to convert their investment into equity at a lower price than the new investors in the next financing round. The valuation cap sets a maximum valuation at which the conversion will occur, providing a similar level of downside protection as a SAFE. One of the key differences between convertible notes and SAFEs is the maturity date. The maturity date on a convertible note can create a sense of urgency for the company to raise a priced financing round. If the company is unable to do so before the maturity date, it may be forced to repay the debt, which could be a significant financial burden for an early-stage company. This is a key reason why many founders now prefer the flexibility of SAFEs. For founders considering the corporate structure of their US entity, our article onShould You Choose a U.S. LLC or C-Corp for Your U.S. Expansion? offers valuable insights.

Key Considerations for UK Founders

When deciding between SAFE notes and convertible notes, UK founders should consider a number of factors. The simplicity and founder-friendly nature of SAFEs can be very appealing, particularly for very early-stage companies that are not yet ready for a formal valuation. The lack of a maturity date and interest payments can also be a significant advantage, as it reduces the financial pressure on the company. However, some investors may prefer the familiarity and debt-like features of convertible notes. The maturity date on a convertible note can provide a clear timeline for the company to raise a priced financing round, which can be seen as a positive by some investors. It is also important to consider the legal and tax implications of each instrument. SAFEs are a relatively new instrument, and the legal and tax treatment of them can be less certain than that of convertible notes. UK founders should also be aware that the terms of both SAFEs and convertible notes can be heavily negotiated. It is important to work with experienced legal counsel to ensure that the terms of the agreement are fair and that they align with the company’s long-term goals. Ultimately, the choice between a SAFE and a convertible note will depend on the specific circumstances of the company, the preferences of the investors, and the long-term fundraising strategy. By carefully considering these factors, UK founders can choose the instrument that is right for them and set their company up for success in the US market.